Galderma announced that AKLIEF® has completed the European decentralised procedure which will result in approval by all involved European member states Galderma announced that AKLIEF® (trifarotene 50 mcg/g cream) has concluded its European decentralised procedure resulting in the approval of its summary of product characteristics, package leaflet, and labelling, by all involved European member states. Each of the 16 concerned ...